Cannabis M&A Lawyer

Cannabis business mergers and acquisitions (M&A) carry greater regulatory risk than standard transactions, affecting deal structures, valuations and future operations.

Speak to a cannabis M&A lawyer at Kight Law to assess your legal risk and make more informed decisions.

Our Cannabis M&A Legal Services

Most mergers and acquisitions within the hemp and cannabis sector depend on whether licenses, ownership structures, product lines and supply chain relationships remain compliant after a change in control.

At Kight Law, we advise cannabis businesses on key legal considerations, including:

  • Transaction structure: Assessing how legal and regulatory issues may affect the way a deal is structured
  • Due diligence: Reviewing licensing, compliance, contracts and operational risk before a transaction moves forward
  • Ownership changes: Understanding how ownership, control or management changes may affect licensed cannabis operations
  • Market and product risk: Evaluating how state-by-state rules and product classification affect deal value and future operations
  • Commercial agreements: Reviewing contracts, supply chain relationships and other obligations that may affect the transaction

Why Work with Rod Kight

Rod Kight advises cannabis, hemp and cannabinoid businesses on complex legal and regulatory issues across the US and internationally.

Why Rod?

Contact Rod Kight

Contact Rod Kight

First
Last

Experience and Services

Kight Law advises cannabis and hemp businesses on how legal and regulatory issues can affect transactions, ownership changes and commercial risk.

This includes assessing how licenses, compliance obligations, contracts and product classification may influence deal structure, diligence findings and post-closing operations.

By connecting transaction strategy with cannabis-specific legal risk, we help businesses make more informed decisions before buying, selling, merging with or investing in a cannabis business.

Speak to a cannabis M&A lawyer about your next move.

The DEA discussed THCA in a recent letter.

Our team

Rod Kight Discusses Trump's Marijuana Rescheduling Order.

Rod Kight

Founder and Lawyer

Cannabis Business Law Articles

 

Cannabis Intellectual Property- Do Your Products Violate A Patent?

By Rod Kight | August 27, 2018
I am not exaggerating when I say that the future of your cannabis business, and the industry at large, may depend on the outcome of this case.

FDA Approves CBD Medication

By Rod Kight | June 25, 2018
The FDA approved Epidiolex, a marijuana derived CBD medication manufactured by GW Pharmaceuticals, today. Epidiolex is an oral solution for…

WHO Issues Glowing Report of CBD But Misstates the Law

By Rod Kight | June 12, 2018
The World Health Organization (WHO) issued a Critical Review Report (Report) on cannabidiol (CBD) on June 7, 2018. The Report…

Did the Federal Right to Try Act Just Legalize Medical Marijuana?

By Rod Kight | May 31, 2018
No. So why am I writing about it? I feel compelled to clear things up. I’ve heard and read a…

our cannabis law services

Farming & Production

Growers & Producers

Products

Processors & Manufacturers

Providers

Distributors & Retailers

Pharmaceuticals

Science & Medicine

Honors & Recognitions

 

  • Listed in North Carolina Super Lawyers and Super Lawyers Rising Stars

    Rod was selected to North Carolina Super Lawyers Rising Stars in 2012 and to the North Carolina Super Lawyers main list since 2015

  • Recognized by Business North Carolina Legal Elite

    Selected to Business North Carolina Legal Elite Bankruptcy Section 2016-2017

  • AVVO Superb Rated Lawyer

    10.0 Rating on Avvo; 28 5-Star Client Reviews and counting.

  • Avvo Client Choice Award

    Avvo Client Choice Award Recipient 2015

  • AV Preeminent Peer Rated Lawyer at Martindale Hubbell

    AV Preeminent Peer Rated Lawyer by Martindale Hubbell since 2014